Santa Monica, CA – According to filings with the U.S. Securities and Exchange Commission, Avenda Health is raising $13,583,348.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Shyam Natarajan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Avenda Health

The Avenda Health platform delivers targeted treatment through focal laser ablation, which minimizes impact to healthy tissue. When compared to competing technologies, this male lumpectomy is relatively inexpensive (no operating room), simple (local anesthesia), and quick (45 mins). Tens of thousands of men each year with prostate cancer seek treatments that impact their quality of life with significant risks of urinary or sexual dysfunction. At Avenda Health, we believe patients should not have to choose between treating their prostate cancer and keeping their quality of life.

To learn more about Avenda Health, visit http://www.avendahealth.com/

Contact:
Shyam Natarajan, Chief Executive Officer
310-957-5202
https://www.linkedin.com/in/shyam-natarajan-71014033/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved